CEP192 Activators are a diverse set of chemical compounds that indirectly promote the functional activity of CEP192 through a variety of signaling pathways and cellular processes. Forskolin and Phorbol 12-myristate 13-acetate (PMA) are instrumental in this regard; the former raises intracellular cAMP levels, thereby activating PKA that may phosphorylate substrates linked to the microtubule organizing center, a domain where CEP192 plays a critical role. On the other hand, PMA, by activating PKC, potentially enhances the phosphorylation of proteins that influence microtubule dynamics, which is essential for the localization and stabilization of CEP192 at spindle poles during mitosis. Similarly, compounds such as Epigallocatechin gallate (EGCG) and the PI3K inhibitors LY294002 and Wortmannin may indirectly bolster CEP192's role in centrosome maturation and spindle assembly by modifying kinase activity and downstream signaling. Moreover, U0126 and Thapsigargin contribute to the activation of CEP192 by altering MAPK/ERK and calcium-dependent signaling pathways, respectively, impacting microtubule stability and centrosome functionality.
The activity of CEP192 is further influenced by Nicotinamide mononucleotide (NMN) and Resveratrol, which enhance NAD+ biosynthesis and activate SIRT1. These actions may lead to deacetylation processes that regulate microtubule organization, thereby supporting CEP192's role in spindle assembly. ZM447439 and PD 0332991 (Palbociclib) also play a part in the activation of CEP192; the former as an Aurora kinase inhibitor may alter the phosphorylation state of key proteins related to centrosome maturation, while the latter, a CDK4/6 inhibitor, may modify cell cycle progression and centrosome duplication processes. Through these varied mechanisms, these activators collectively support the enhancement of CEP192's essential functions in cell division, specifically its roles in centrosome duplication, maturation, and spindle assembly, without the need to upregulate its expression or directly activate the protein.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, leading to increased levels of cAMP. Elevated cAMP activates PKA, which can phosphorylate specific substrates that may enhance the assembly of the microtubule organizing center where CEP192 is localized. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC), which can phosphorylate proteins associated with microtubule dynamics, potentially increasing the localization or stabilization of CEP192 at the spindle poles during mitosis. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to inhibit several protein kinases, altering signaling pathways and possibly leading to the increased activity of pathways that promote the function of CEP192 in centrosome maturation and spindle assembly. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate acts through G protein-coupled receptors to activate signaling cascades that can lead to cytoskeletal rearrangements, possibly supporting the role of CEP192 in microtubule nucleation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which may lead to decreased AKT activity, potentially enhancing the role of CEP192 in centrosome duplication and separation by affecting downstream signaling proteins. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor that could similarly enhance CEP192's function by modulating signaling pathways involved in centrosome dynamics and spindle formation during cell division. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin raises intracellular Ca2+ levels, which may activate calcium-dependent signaling pathways indirectly enhancing the function of CEP192 in centrosome maturation and spindle assembly checkpoint control. | ||||||
β-Nicotinamide mononucleotide | 1094-61-7 | sc-212376 sc-212376A sc-212376B sc-212376C sc-212376D | 25 mg 100 mg 1 g 2 g 5 g | $110.00 $150.00 $220.00 $300.00 $600.00 | 4 | |
NMN enhances NAD+ biosynthesis, which could support the function of CEP192 through sirtuin-mediated deacetylation processes that are involved in the regulation of microtubule organization and centrosome function. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates SIRT1, which may deacetylate tubulin and affect microtubule dynamics, potentially supporting the role of CEP192 in spindle assembly and centrosomal linking to microtubules. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
PD 0332991 is a CDK4/6 inhibitor that may indirectly enhance CEP192's role by modifying the cell cycle progression and centrosome duplication processes, as CEP192 is critical for proper centrosome function. | ||||||